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A ntibiotic resistance dramatically reduces the effectiveness of existing treatment options for clinical bacterial infections. Antibiotic-resistant organisms can result in recalcitrant infections that are challenging to treat with existing antibiotics, leading to >20,000 deaths a year (1) . Concurrently, the antibacterial discovery pipeline has shrunk dramatically, and ongoing clinical trials for antibacterials often feature derivatives of compounds for which resistance mechanisms already exist (2) . Recent attention has centered on drug-resistant Gram-negative bacteria such as carbapenem-resistant Enterobactericeae (CRE) (3, 4) . These strains can use degradative enzymes, such as New Delhi metallo-beta-lactamase-1 (NDM-1), which can hydrolyze beta-lactam antibiotics (5) . New treatment regimens and adjuvants to combat antibiotic resistance are urgently needed (6, 7) .
Previously, we showed that overexpressing single genes from constructs that are delivered into bacteria via engineered bacteriophages could potentiate the lethality of antibiotics in wildtype and quinolone-resistant Escherichia coli carrying a chromosomal gyrA mutation (8) . Expression of one of these genes, lexA3, suppressed the SOS network that is normally activated in response to antibiotic treatment (9) (10) (11) (12) . In addition, we demonstrated that overexpression of the double gene combination csrA + ompF had enhanced antibiotic-potentiating efficacy compared with its individual gene constituents (8) . However, this study identified the single genes and the gene pair via a laborious one-by-one testing protocol using a candidate gene approach informed by previous studies (9) (10) (11) (12) (13) (14) . Based on this strategy, it would take on the order of n 2 steps [abbreviated O(n 2 ), using order notation from computer science] to construct all pairwise combinations of n genes and another O(n 2 ) experiments to test their efficacy. The brute-force nature of this approach restricts the scale and combinatorial complexity that can be tested when trying to identify pathways that can modulate antibiotic-resistance phenotypes.
To overcome these limitations, we developed a high-throughput platform for the identification of genetic combinations that potentiate antibiotic activity against clinically relevant drugresistance determinants. Here, we describe a technology, termed Combinatorial Genetics En Masse (CombiGEM) , that enables the rapid generation of high-order barcoded combinations of genetic elements for high-throughput multiplexed characterization based on next-generation sequencing. We applied CombiGEM to identify genetic combinations that enhance the effectiveness of antibiotics against CRE. CombiGEM uses an iterative cloning strategy beginning with a library of barcoded DNA elements (Fig. 1A) . Restriction digests of pooled vector and insert libraries, followed by a one-pot ligation reaction, create a library of genetic combinations with the barcodes in close proximity to one another. As a result, the identities of each of the genetic components in a particular construct can be determined by reading the contiguous DNA barcode sequences Significance Many complex biological phenotypes are multifactorial in nature, yet current strategies for studying biological systems are limited by the inability to generate and track complex combinatorial cellular perturbations in a scalable fashion. Here, we introduce a method, Combinatorial Genetics En Masse (CombiGEM), that allows both facile generation of high-order combinations and high-throughput characterization of pooled populations using next-generation sequencing. We apply CombiGEM to identify genetic combinations that enhance killing of highly antibiotic-resistant bacteria with antibiotics, thus providing potential targets for antimicrobial development. We envision that CombiGEM will be broadly useful for basic science and biotechnology applications, such as complex genetic screening, identification of novel drug targets, interactome mapping, and synthetic circuit characterization.
with high-throughput sequencing. From the newly produced combinatorial library, higher-order combinations can be generated in fixed amounts of time by using the same procedure, rather than in exponentially increasing amounts of time. Therefore, combinatorial libraries can be constructed in a pooled format without needing to barcode each combination within an individual reaction. A similar DNA assembly method was described for optimizing translational rates in metabolic pathways, in which hits were individually sequenced to identify the hit components (15) . In contrast, we use high-throughput sequencing to census the distribution of library members within pooled populations in a highly multiplexed manner. By comparing these distributions, we identify changes in the population under different experimental conditions to link combinatorial genotypes to specific phenotypes. We anticipate that CombiGEM will be a broadly useful tool for identifying genetic combinations conferring a desired phenotype and for altering the gene expression profile of a cell.
Results
Combinatorial Library Generation and Functional Validation. In this study, 173 E. coli transcription factors (TFs) and 18 fluorescent proteins were placed under the control of the anhydrotetracycline (aTc)-inducible P L tetO promoter (SI Appendix, Fig. S1 , and Dataset 1). The TFs chosen represent nearly all E. coli TFs identified in RegulonDB (16) . These expression constructs were uniquely barcoded and combined through CombiGEM to yield 35,343 possible pairwise combinations (189 ORFs × 187 ORFs, because some ORFs were rejected due to undesirable cleavage by restriction enzymes). This pairwise library was introduced into an E. coli MG1655 strain by electroporation and sequenced on the Illumina HiSeq platform, which resulted in the recovery of 34,554 combinations-or 98% of all possible combinationsdistributed across the population (Fig. 1B) . To ensure that inserts remained intact, we isolated and sequenced 50 library members and confirmed that all 50 retained both genetic expression constructs, including the genes, promoters, and ribosomebinding sequences.
To assess expression levels from our combinatorial genetic constructs, including the influence of gene order on expression levels, we measured fluorescence from all four pairwise combinations of GFP and mCherry as well as single GFP and mCherry constructs (SI Appendix, Fig. S2 ). We observed comparable fluorescence levels for both fluorescent proteins with the GFPmCherry and mCherry-GFP constructs and approximately double fluorescence signal levels for GFP-GFP and mCherrymCherry compared with the single gene constructs (SI Appendix, Fig. S3A ). We also verified the ability of CombiGEM to scale beyond pairwise libraries through cloning of barcoded GFP and mCherry inserts to reach three-wise and four-wise combinatorial constructs (SI Appendix, Figs. S3 B-D and S4). Flow-cytometry analysis of higher-order combinations showed stepwise increases in fluorescence with each additional fluorescent gene and comparable fluorescence levels regardless of gene order when the number of fluorescence genes was held constant (SI Appendix, Fig. S3D ).
CombiGEM Library Screening for Genetic Combinations That
Modulate Antibiotic Killing. We applied CombiGEM to discover TF combinations in our library that could modulate antibiotic activity against drug-resistant NDM-1 E. coli. We first determined the minimal inhibitory concentrations (MICs) for a range of antibiotics against an E. coli NDM-1 strain and found that this MIC profile resembled those of published NDM-1 clinical isolates (SI Appendix, Table S1 ). This NDM-1 strain was resistant to ceftriaxone, a third-generation cephalosporin with broad-spectrum activity that is used clinically to treat pneumonia, bacterial meningitis, and gonorrhea (17, 18) . We then introduced the barcoded pairwise TF library into the E. coli NDM-1 strain by electroporation. We primarily sought to identify TF combinations that could enhance the activity of existing antibiotics to which E. coli NDM-1 was resistant. We subjected pooled NDM-1 strains containing the barcoded pairwise TF combinatorial libraries to a two-by-two matrix of conditions that included media with or without aTc induction and media with or without ceftriaxone treatment (Fig. 1C) . We harvested bacterial cultures under each condition at early and late logarithmicgrowth stages to observe shifting distributions in the barcoded populations over time. These samples were multiplexed for highthroughput sequencing on the Illumina HiSeq platform (19) . E. coli NDM-1 cells containing a CombiGEM library were diluted into cultures with and without anhydrotetracycline (aTc) and grown to middle logarithmic phase. Each culture was then further diluted into cultures with and without antibiotic (Abx), and with and without aTc. DNA from each condition was harvested at early and late logarithmic-growth stages and processed for high-throughput sequencing (HT-seq) with Illumina HiSeq. Comparisons of abundances of barcoded gene combinations among different conditions revealed genotypes that conferred desired phenotypes. (D) Heatmap of S scores for specific hits across experiments. Combinations marked as potentiating combinations represent genetic combinations that drop out upon addition of both ceftriaxone and aTc. Neutral combinations showed neutral S scores in the presence of both ceftriaxone and aTc. Ceftriaxone was applied in two different concentrations: 64 μg/mL (low) and 256 μg/mL (high). Gene pairs correspond to numbers 1, qseB + bolA; 2, lrp + xylR; 3, eCFP + norR; and 4, pdhR + yohL.
To determine the influence of each combination on NDM-1 viability, we computed statistical S scores to compare each combination's abundance in a particular experimental condition against its abundance in other experiments (SI Appendix). Combinations that were underrepresented in the presence of aTc + ceftriaxone, compared with the other experimental conditions, suggested that expression of those gene combinations conferred potentiation of ceftriaxone. For validation, we randomly selected potentiating hits from the 200 top-scoring combinations, as well as controls with neutral S scores ( Table 1) . Hierarchical clustering on the combinations and their scores in each experiment showed clustering by phenotype class (Fig. 1D) . To gauge the influence of gene order in our expression construct, we also performed hierarchical clustering on these combinations and their reciprocal configurations. The combinations of the same phenotype clustered together regardless of gene order in the constructs (SI Appendix, Fig. S5 ).
Validation of Hits via Time-Kill Curves. To validate the activity of these combinations, we cloned each gene pair and tested their activity individually in time-kill assays against NDM-1 E. coli (Fig. 2) . Each strain was grown to early logarithmic phase and treated with and without ceftriaxone and with and without aTc. Aliquots were serially diluted and plated to measure viable cell densities over 10 h after initiation of treatment. Combinations identified as leading to potentiation of killing showed significant amplification of killing by up to 3-5 orders of magnitude in the presence of aTc + ceftriaxone compared with ceftriaxone alone or aTc alone ( Fig. 2A) . The potentiating combinations also showed significantly greater killing compared with control combinations that were randomly selected for relatively neutral S scores, as well as the NDM-1 E. coli strain with no genetic combinations ( Fig. 2B and SI Appendix, Fig. S6 ). In addition, the gene combinations exhibited significantly higher potentiation of antibiotic activity as pairwise combinations compared with individual genes, potentially indicating unexpected synergy (Fig.  2C) . The potentiating combinations conferred a transient lethality, and the cultures did regrow over time. This regrowth was seen in all antibiotic-treated samples and could be due to antibiotic degradation, resistant subpopulations, or other mechanisms that are yet to be determined.
To further study whether CombiGEM could identify genetic combinations across a range of antibiotics, we exposed the pairwise combinatorial library to the beta-lactam imipenem, the combination beta-lactam and -lactamase inhibitor piperacillintazobactam, and the aminoglycoside antibiotic gentamicin. Along with ceftriaxone, each antibiotic is used widely in clinical scenarios and is highly resisted by the NDM-1 strain (20) (21) (22) . We performed hierarchical clustering of the top hits across all conditions based on S scores. Hits for the beta-lactam antibiotics in the presence of aTc clustered together-likely due to their similar mechanisms of action-and separately from gentamicin, likely due to their distinct mechanisms of action (SI Appendix, Fig. S7 ). Identifying Lethal Genetic Combinations Through CombiGEM. We next questioned whether CombiGEM could identify combinations of genes that were significantly lethal upon overexpression but that would also enhance bacterial killing by ceftriaxone. We identified the strongest lethal combinations by calculating the log-ratio of abundances between conditions with and without aTc, averaged across treatments with ceftriaxone and no ceftriaxone (SI Appendix). We selected random combinations from the top 200 hits with the lowest log ratios (Table 1) . We discovered combinations that showed up to 6 orders of magnitude greater killing of the bacterial population when used in combination with ceftriaxone compared with ceftriaxone alone (Fig.  3A) . Furthermore, in the absence of concomitant antibiotic treatment, hits identified from the log-ratio method showed greater lethality upon induction with aTc (Fig. 3A) compared with hits identified through the S-score method ( Fig. 2A) .
Because a majority of E. coli ORFs have been reported to show growth inhibition upon induction (23), we constructed random combinations containing previously identified toxic genes to assess whether CombiGEM could identify especially lethal combinations (23) . Combinations identified through the log-ratio method showed 1-3 orders of magnitude greater killing at the points of lowest cell density compared with random combinations of toxic genes, as well as longer sustained killing over the period of 10 h tested (Fig. 3 A and B) . We also assessed whether the large killing effects of the genetic combinations were enhanced over that of the two constituent genes individually (Fig. 3C and SI Appendix, Fig. S8 ). Although torR and metR were toxic and increased antibiotic killing when expressed individually, the combination of the two genes resulted in greater lethal effects against NDM-1 bacteria (Fig. 3C) . CombiGEM can therefore isolate combinatorial perturbations leading to strong phenotypes that are not ex ante apparent from the combination's individual constituents.
Gene combinations identified through CombiGEM could be effective adjuvants for antibiotic treatment if delivered, for example, by phage. Previous studies have shown reductions in bacterial resistance (8, 24) and persistence (8) via phage delivery of gene expression constructs, but they relied on candidate gene approaches rather than high-throughput experimental screening as shown here. We packaged combinatorial genetic expression phagemids (identified in Fig. 3A ) into M13 phage particles and infected an E. coli EMG2 NDM-1 strain (Fig. 4A) . After 30 min of infection, aTc and ceftriaxone were added where appropriate, and viable cell counts were obtained on the bacterial cultures. The induction of gene combinations identified above in conjunction with ceftriaxone led to enhanced bacterial killing of 1-2 orders of magnitude compared with ceftriaxone alone, whereas a control phage showed no improvement (Fig. 4B ). These results demonstrate that combinatorial genetic targets identified through this high-throughput approach can increase the killing of drugresistant bacteria with antibiotic treatment.
Scalability of CombiGEM Assembly to Higher-Order Libraries. To validate the scalability of the CombiGEM technology to higherorder combinations, we constructed three-wise combination libraries from the pairwise TF library with one-pot reactions. We first produced a lower-complexity library combining 189 × 187 × 18 genes. Out of 636,174 possible combinations, we recovered 582,433 unique combinations (92% of all possible combinations) from ∼30 million Illumina sequencing reads (SI Appendix, Fig.  S9A ). We also produced a higher-complexity library combining 189 × 187 × 187 genes. Out of 6,609,141 possible gene combinations, we recovered 4,042,316 combinations (61%) from ∼20 million sequencing reads (SI Appendix, Fig. S9B ). Greater library coverage could likely be achieved by scaling up bacterial transformations of the libraries and dedicating a greater number of sequencing reads to each sample.
Discussion
In this study, we applied CombiGEM to identify TF combinations conferring strong phenotypes relevant to combating antibiotic resistance, including enhancement of bacterial killing by beta-lactam antibiotics against antibiotic-resistant E. coli NDM-1 strains. Most of the single genes and their combinations identified here have not been reported to directly mediate enhanced killing by antibiotics. For instance, qseB and bolA are implicated in pathways associated with virulence (25) and stress response (26) , respectively, and show significantly higher potentiation of antibiotic activity as pairwise combinations compared with the individual genes. Thus, CombiGEM can reveal unexpected interactions between pathways yielding strong phenotypes and empower systems-biology approaches to uncovering network interactions. Future work should explore potential mechanisms of action of these genetic combinations on antibiotic efficacy, which could be due to reduction of antibiotic hydrolysis, influencing drug uptake or efflux, increasing the effectiveness of residual antibiotic, or other effects.
Genetic combinations identified through CombiGEM-based screens could potentially enhance the treatment of bacterial infections by revealing pathways that modulate antibiotic resistance and by providing targets for drug screening. The TFs identified in this study may not be optimal targets themselves for drug screening given the challenges associated with modulating TFs with small molecules (27) . However, analysis of the downstream targets modulated by TF combinations using transcriptomic and proteomic approaches could help to identify candidate genes for further study. For example, the transcriptomic profiles of cells with specific genetic combinations could be compared with cells containing the corresponding constituent components as well as wild-type cells to identify genes that are uniquely up-or down-regulated. These genes could then be knocked out, knocked down, or overexpressed individually, and in combination with each other, to map their effects on antibiotic activity.
In future work, CombiGEM could also be used to barcode and screen combinatorial genetic knockdowns based on approaches such as antisense RNA (28) and CRISPR interference (29, 30) . The potential advantage of screening for combinatorial knockdowns that enhance antibiotic efficacy is that such candidates could be more easily adapted into drug screening pipelines for small-molecule inhibitor screens. These drugs could then be delivered in combination treatment with antibiotics to improve antimicrobial activity. However, there are associated challenges with delivering combinatorial therapies to target sites at the same time that may need to be overcome (31) .
In this work, we primarily studied the effects of beta-lactam antibiotics, but the study can be extended to a greater variety of antibiotics. Furthermore, the antibiotics can be dosed over a range of concentrations, and the samples can be assayed at multiple time points to provide greater insights into the interactions between genetic combinations and potential timedependent and/or concentration-dependent effects. For example, beta-lactam antibiotics exhibit time-dependent killing, whereas quinolone antibiotics exhibit concentration-dependent killing (32) . Moreover, the workflow described in this study identifies combinations generally leading to a drop in representation in the library population and does not explicitly distinguish between bacteriostatic vs. bactericidal activity. However, the protocol could be further adapted to identify combinations with such distinct behaviors, for example by quantifying barcode frequencies relative to standard combinations that have known phenotypes.
More generally, multifactorial genetics are integral to many complex biological phenomena. Discovery of the underlying combinatorial effectors has been limited by current methods but can be enabled by CombiGEM. Differentiation (33, 34) and reprogramming (35) protocols, such as those for inducing pluripotent stem cells (36) , require specific combinations of factors that are typically discovered through nonmultiplexed and laborintensive processes. Similarly, combinatorial drug therapy can achieve greater efficacy than individual drugs in disease management (37), but validating large numbers of drug-target combinations is difficult. Finally, methods such as genome-wide association studies have discovered numerous loci putatively involved in complex diseases, such as heart disease (38) and diabetes (39), but aggregated individual loci usually account for only a minor fraction of the disease heritability (40) . Epistatic interactions between genes have been suggested to account for part of this "missing heritability," (41, 42) but experimentally validating large numbers of such interactions is difficult. In particular, current methods for screening combinatorial genetic perturbations are limited in throughput and complexity. Singlegene overexpression and knockout libraries (23, 43) can be screened for cellular phenotypes but lack combinatorial complexity. Methods such as synthetic genetic arrays (44, 45) or double plasmid transformations enable pairwise gene combination studies but require time-intensive screening of individual clones. Pooled PCR stitching methods, such as Stitch-Seq (46), permit higher-throughput screening of pairwise genetic perturbations for interactome mapping. However, these methods are challenging to scale to three-wise and even higher-order genetic combinations.
In contrast to existing techniques, next-generation sequencing applied to the scalable CombiGEM assembly strategy enables multiplexed tracking of pooled combinatorial populations. By using this strategy, the one-time construction of the initial library containing n members proceeds in linear [or O(n)] time, scaling the library an order higher (e.g., from a pairwise n × n library to a three-wise n × n × n library, and so forth) proceeds in constant [or O(1)] time, and characterization of any of the combinatorial libraries proceeds in O(1) time. The CombiGEM strategy is flexible and can be used to build high-order combinations of other DNA elements, including gene-expression and knockdown (47, 48) constructs, synthetic circuit components, and genomic sequences, all of which are readily available in libraries. We have focused on antibiotic-resistant bacteria in this study, but this approach can also be generalized to study combinatorial genetics in other model organisms, including other bacterial pathogens, simple eukaryotes such as yeast, and human cells. For example, combinatorial genetic studies in Staphylococcus aureus and Pseudomonas aeruginosa could be performed by constructing libraries in E. coli on shuttle vectors, adapting expression constructs with validated promoters and ribosomebinding sequences from the target species, and performing bacterial transformation of these libraries into S. aureus and P. aeruginosa for testing. Factors to consider when extending CombiGEM to other organisms include the availability of tractable genetic tools, the efficiency of DNA delivery, the scale of cell culturing, and thus the possible library complexity that can be screened.
In future work, CombiGEM could also be extended to generate complex interactome datasets (49) , screen for combinatorial regulators of desired phenotypes such as differentiation (36) , identify potentiators of anticancer drugs (50), enhance pathway engineering (15) , and characterize synthetic circuits at greater scales (51) (52) (53) (54) (55) . The CombiGEM assembly strategy can be adapted to isothermal Gibson assembly (56) or recombinases (57) in situations where the library is incompatible with restriction sites. In summary, by leveraging one-pot combinatorial DNA assembly with highly multiplexed DNA sequencing of combinatorial barcodes, CombiGEM collapses high-dimensional combinatorial genetic studies into straightforward procedures. We envision that high-throughput strategies for probing multifactorial phenotypes and emergent network properties will contribute to our understanding of complex biological systems and their applications.
Methods
Gene expression constructs were created through isothermal Gibson assembly. Further experimental methods are available in SI Appendix. Details of data analysis are also found in SI Appendix.
